Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome. https://t.co/wGNywNkd1S
RT @ANMSociety: Research into #biomarkers has potentially ID'd one for #IBS-D. sTREM-1 was significantly higher in IBS-D patients, compared…
RT @ANMSociety: Research into #biomarkers has potentially ID'd one for #IBS-D. sTREM-1 was significantly higher in IBS-D patients, compared…
RT @ANMSociety: Research into #biomarkers has potentially ID'd one for #IBS-D. sTREM-1 was significantly higher in IBS-D patients, compared…
RT @ANMSociety: Research into #biomarkers has potentially ID'd one for #IBS-D. sTREM-1 was significantly higher in IBS-D patients, compared…
Research into #biomarkers has potentially ID'd one for #IBS-D. sTREM-1 was significantly higher in IBS-D patients, compared to controls, and was positively associated with abdominal pain scores. Presence of sTREM-1 may indicated sub-clinical inflammation.